S&P 500   4,575.32 (+0.52%)
DOW   35,651.52 (+0.45%)
QQQ   381.86 (+0.49%)
AAPL   149.85 (+0.67%)
MSFT   324.45 (+0.40%)
FB   314.70 (+0.79%)
GOOGL   2,937.20 (+0.44%)
TSLA   1,067.15 (+2.82%)
AMZN   3,409.00 (+0.49%)
NVDA   247.33 (+1.15%)
BABA   169.11 (-0.07%)
NIO   39.68 (+0.94%)
CGC   12.87 (+0.70%)
AMD   123.27 (+0.81%)
MU   69.26 (+1.49%)
T   25.13 (+0.28%)
F   16.93 (+9.16%)
DIS   170.10 (+0.32%)
PFE   43.01 (+0.09%)
BA   206.80 (+0.09%)
AMC   35.28 (+1.50%)
S&P 500   4,575.32 (+0.52%)
DOW   35,651.52 (+0.45%)
QQQ   381.86 (+0.49%)
AAPL   149.85 (+0.67%)
MSFT   324.45 (+0.40%)
FB   314.70 (+0.79%)
GOOGL   2,937.20 (+0.44%)
TSLA   1,067.15 (+2.82%)
AMZN   3,409.00 (+0.49%)
NVDA   247.33 (+1.15%)
BABA   169.11 (-0.07%)
NIO   39.68 (+0.94%)
CGC   12.87 (+0.70%)
AMD   123.27 (+0.81%)
MU   69.26 (+1.49%)
T   25.13 (+0.28%)
F   16.93 (+9.16%)
DIS   170.10 (+0.32%)
PFE   43.01 (+0.09%)
BA   206.80 (+0.09%)
AMC   35.28 (+1.50%)
S&P 500   4,575.32 (+0.52%)
DOW   35,651.52 (+0.45%)
QQQ   381.86 (+0.49%)
AAPL   149.85 (+0.67%)
MSFT   324.45 (+0.40%)
FB   314.70 (+0.79%)
GOOGL   2,937.20 (+0.44%)
TSLA   1,067.15 (+2.82%)
AMZN   3,409.00 (+0.49%)
NVDA   247.33 (+1.15%)
BABA   169.11 (-0.07%)
NIO   39.68 (+0.94%)
CGC   12.87 (+0.70%)
AMD   123.27 (+0.81%)
MU   69.26 (+1.49%)
T   25.13 (+0.28%)
F   16.93 (+9.16%)
DIS   170.10 (+0.32%)
PFE   43.01 (+0.09%)
BA   206.80 (+0.09%)
AMC   35.28 (+1.50%)
S&P 500   4,575.32 (+0.52%)
DOW   35,651.52 (+0.45%)
QQQ   381.86 (+0.49%)
AAPL   149.85 (+0.67%)
MSFT   324.45 (+0.40%)
FB   314.70 (+0.79%)
GOOGL   2,937.20 (+0.44%)
TSLA   1,067.15 (+2.82%)
AMZN   3,409.00 (+0.49%)
NVDA   247.33 (+1.15%)
BABA   169.11 (-0.07%)
NIO   39.68 (+0.94%)
CGC   12.87 (+0.70%)
AMD   123.27 (+0.81%)
MU   69.26 (+1.49%)
T   25.13 (+0.28%)
F   16.93 (+9.16%)
DIS   170.10 (+0.32%)
PFE   43.01 (+0.09%)
BA   206.80 (+0.09%)
AMC   35.28 (+1.50%)
NASDAQ:LFST

LifeStance Health Group Stock Forecast, Price & News

$11.39
-0.20 (-1.73 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$11.20
$11.70
50-Day Range
$11.36
$23.30
52-Week Range
$10.67
$29.81
Volume
266,972 shs
Average Volume
1.19 million shs
Market Capitalization
$4.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive LFST News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter.


About LifeStance Health Group

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LFST
Employees
2,674
Year Founded
N/A

Sales & Book Value

Annual Sales
$265.56 million

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$4.26 billion
Next Earnings Date
11/8/2021 (Confirmed)
Fiscal Year End
December 31
Optionable
Not Optionable

MarketRank

Overall MarketRank

2.13 out of 5 stars

Medical Sector

450th out of 1,372 stocks

Health Services Industry

4th out of 13 stocks

Analyst Opinion: 3.4Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












LifeStance Health Group (NASDAQ:LFST) Frequently Asked Questions

Is LifeStance Health Group a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeStance Health Group in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LifeStance Health Group stock.
View analyst ratings for LifeStance Health Group
or view top-rated stocks.

What stocks does MarketBeat like better than LifeStance Health Group?

Wall Street analysts have given LifeStance Health Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but LifeStance Health Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting LifeStance Health Group?

LifeStance Health Group saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 5,820,000 shares, an increase of 56.0% from the September 15th total of 3,730,000 shares. Based on an average trading volume of 1,310,000 shares, the days-to-cover ratio is currently 4.4 days. Approximately 8.5% of the shares of the stock are short sold.
View LifeStance Health Group's Short Interest
.

When is LifeStance Health Group's next earnings date?

LifeStance Health Group is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for LifeStance Health Group
.

How can I listen to LifeStance Health Group's earnings call?

LifeStance Health Group will be holding an earnings conference call on Monday, November 8th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were LifeStance Health Group's earnings last quarter?

LifeStance Health Group, Inc. (NASDAQ:LFST) posted its quarterly earnings results on Wednesday, August, 11th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.16. The firm had revenue of $160.55 million for the quarter, compared to analyst estimates of $156.46 million.
View LifeStance Health Group's earnings history
.

What guidance has LifeStance Health Group issued on next quarter's earnings?

LifeStance Health Group updated its FY 2021 earnings guidance on Wednesday, September, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $668 million-$678 million.

What price target have analysts set for LFST?

7 Wall Street analysts have issued 12-month target prices for LifeStance Health Group's stock. Their forecasts range from $16.00 to $36.00. On average, they anticipate LifeStance Health Group's share price to reach $27.50 in the next year. This suggests a possible upside of 141.4% from the stock's current price.
View analysts' price targets for LifeStance Health Group
or view top-rated stocks among Wall Street analysts.

Who are LifeStance Health Group's key executives?

LifeStance Health Group's management team includes the following people:
  • Mr. Michael K. Lester, Chairman, CEO & Pres (Age 65, Pay $798.43k)
  • Ms. Gwendolyn H. Booth, Chief Operating Officer (Age 49, Pay $480k)
  • Mr. Danish J. Qureshi, Chief Growth Officer (Age 37, Pay $399.86k)
  • Mr. Jesse Michael Bruff, CFO & Treasurer (Age 52)
  • Mr. Warren Gouk, Chief Admin. Officer
  • Mr. Ryan Pardo, Chief Legal Officer & Sec. (Age 45)
  • Ms. Felicia Gorcyca, Chief People Officer (Age 42)
  • Mr. Pablo Pantaleoni, Chief Digital Officer (Age 33)
  • Mr. Kevin Michael Mullins, Chief Devel. Officer (Age 36)
  • Dr. Anisha Patel-Dunn D.O., Chief Medical Officer (Age 45)

When did LifeStance Health Group IPO?

(LFST) raised $640 million in an initial public offering (IPO) on Thursday, June 10th 2021. The company issued 40,000,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

What is LifeStance Health Group's stock symbol?

LifeStance Health Group trades on the NASDAQ under the ticker symbol "LFST."

When does LifeStance Health Group's lock-up period expire?

LifeStance Health Group's lock-up period expires on Tuesday, December 7th. LifeStance Health Group had issued 40,000,000 shares in its IPO on June 10th. The total size of the offering was $720,000,000 based on an initial share price of $18.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Who are LifeStance Health Group's major shareholders?

LifeStance Health Group's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include CAPROCK Group Inc. (0.01%) and Strs Ohio (0.00%). Company insiders that own LifeStance Health Group stock include Jeffrey Crisan, Kenneth T Mills, Silversmith Partners I Gp, Llc and Summit Partners Growth Equity.
View institutional ownership trends for LifeStance Health Group
.

Which institutional investors are buying LifeStance Health Group stock?

LFST stock was acquired by a variety of institutional investors in the last quarter, including CAPROCK Group Inc., and Strs Ohio.
View insider buying and selling activity for LifeStance Health Group
or or view top insider-buying stocks.

How do I buy shares of LifeStance Health Group?

Shares of LFST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeStance Health Group's stock price today?

One share of LFST stock can currently be purchased for approximately $11.39.

How much money does LifeStance Health Group make?

LifeStance Health Group has a market capitalization of $4.26 billion and generates $265.56 million in revenue each year.

How many employees does LifeStance Health Group have?

LifeStance Health Group employs 2,674 workers across the globe.

What is LifeStance Health Group's official website?

The official website for LifeStance Health Group is www.lifestance.com.

How can I contact LifeStance Health Group?

The company can be reached via phone at 425-279-8500.


This page was last updated on 10/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.